Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

DMXAA demonstrates antivascular and cytokine-inducing effects in humans

June 1, 2000

Flt-1 receptor-targeting ribozyme shows good tolerance, favorable pharmacokinetics in the clinic

June 1, 2000

Antitumor indenoisoquinolines presented in patent literature

June 1, 2000

Phthalocyanines and their use in cancer PDT patented by Brown

June 1, 2000

Combination of MDR modulator LY-335979 and docetaxel advances to phase II

June 1, 2000

Researchers report Atrigel containing leuprolide acetate may offer clinical advantages

June 1, 2000

Phase I clinical trials assess different schedules of CCI-779, a new signal transduction inhibitor

May 31, 2000

IMC-1C11 exhibits antiangiogenic activity and excellent safety in animal models

May 31, 2000

BioNumerik's anticancer products show promise in early clinical trials

May 31, 2000

Vion initiates phase I trial of Triapine by continuous infusion

May 31, 2000

Popular Stories

NIH changes set industry up for workforce, ideas drought
BioWorld
On March 1, 2025, former NIH director Francis Collins’ announced that he had fully resigned from the NIH, where he continued to lead a laboratory after his...
Today's news in brief
BioWorld
BioWorld briefs for March 13, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for March 13, 2025
At CROI, HIV cure trials raise hopes for broader applicability
BioWorld
At the 2025 meeting of the Conference on Retroviruses and Opportunistic Infections (CROI) it was the best of times, it was the worst of times. On the first full...
Hummingbird migrates ADCs, tech to newco Callio’s $187M debut
BioWorld
Antibody-drug conjugate (ADC)-focused Callio Therapeutics debuted on March 3 with the closing of a $187 million series A financing round based on cancer drug...